CapForce, Inc. (CFOR)
6.02
-0.88
(-12.75%)
USD |
OTCM |
Nov 05, 16:00
CapForce Gross Profit Margin (Quarterly) : 89.90% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 89.90% |
| March 31, 2026 | |
| December 31, 2025 | 88.28% |
| September 30, 2025 | |
| June 30, 2025 | 98.82% |
| March 31, 2025 | |
| December 31, 2024 | 99.09% |
| September 30, 2024 | |
| June 30, 2024 | 95.00% |
| March 31, 2024 | 55.50% |
| December 31, 2023 | -10.11% |
| September 30, 2023 | 1.02% |
| June 30, 2023 | -24.78% |
| March 31, 2023 | 21.11% |
| December 31, 2022 | 25.73% |
| September 30, 2022 | -324.2% |
| June 30, 2022 | 31.56% |
| March 31, 2022 | -23.40% |
| December 31, 2021 | 39.86% |
| September 30, 2021 | 31.27% |
| June 30, 2021 | -4.99% |
| March 31, 2021 | 20.57% |
| December 31, 2020 | 29.19% |
| September 30, 2020 | -42.89% |
| Date | Value |
|---|---|
| June 30, 2020 | 18.66% |
| March 31, 2020 | 32.86% |
| December 31, 2019 | 56.44% |
| September 30, 2019 | 29.27% |
| June 30, 2019 | 55.38% |
| March 31, 2019 | 64.20% |
| December 31, 2018 | 39.01% |
| September 30, 2018 | 29.16% |
| June 30, 2018 | 38.76% |
| March 31, 2018 | 39.57% |
| December 31, 2017 | 35.52% |
| September 30, 2017 | 33.23% |
| June 30, 2017 | 32.95% |
| March 31, 2017 | 31.95% |
| December 31, 2016 | 51.20% |
| September 30, 2016 | 40.53% |
| June 30, 2016 | 57.88% |
| March 31, 2016 | 38.55% |
| December 31, 2015 | 57.84% |
| September 30, 2015 | 18.99% |
| June 30, 2015 | 72.54% |
| March 31, 2015 | 55.36% |
| December 31, 2013 | -138.3% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | -- |
| Agenus, Inc. | 98.50% |
| Amgen, Inc. | 73.09% |
| Anika Therapeutics, Inc. | 65.15% |
| BioCryst Pharmaceuticals, Inc. | 98.99% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 196.8% |
| Return on Assets | 164.7% |
| Return on Invested Capital | 185.2% |
| Profit Margin (Quarterly) | 84.94% |
| Operating Margin (Quarterly) | 88.57% |
| Return on Net Operating Assets | 460.5% |